Skip to content
Catalyst
Preterm birth incidence

21 findings · 9 compounds · 12 null · by evidence strength. No dose is advised.

Fig. 2 Preterm birth incidence9 compounds outer ring on requestSelected Preterm birth incidence · centre
×1.60
Labels
Measured outcomeInspector

Preterm birth incidence

Findings drawn, by strength

21findings · 9 compounds

  • Moderate5
  • Very limited16

Most findings

  • Calcium×7
  • Vitamin A (retinol)×4
  • Zinc×3
  • Folic acid×2
Show the remaining 5Show the first 4
  • Iodine×1
  • L-arginine×1
  • Magnesium×1
  • Myo-inositol×1
  • Selenium×1
Keys

← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it

Compound lowers no difference foundFindingsStrongest
7
Moderate
4
Moderate
3
Very limited
2
Moderate
1
Very limited
1
Moderate
1
Very limited
1
Very limited
1
Moderate

Not pooled · no summary effect · point at a mark · Tab, then the arrow keys

Reported to move it9 findings

  1. SeleniumMoved: lowersEffect, as reportedRR0.32[0.11 to 0.95]Evidence: ModeratePaper: PMID 332757752021
    Who
    HIV-seropositive pregnant women in Lagos, 14–27 weeks gestation at enrolment; all received standard prenatal iron, folic acid and malaria chemoprophylaxis; multivariate-adjusted estimate
    Dose studied
    200 μg elemental selenium tablet daily from enrolment until delivery

    On performing the multivariate analysis of all variables at end-line, mothers on prenatal selenium supplements have a statistically significant lower risk of preterm delivery compared with women in the placebo arm (RR 0.32, 95% CI 0.11–0.95; P = 0.039).”

    Quoted verbatim from Effects of selenium supplementation on pregnancy outcomes and disease progression in HIV-infected pregnant women in Lagos: A randomized controlled trial.RCTPermalink
  2. CalciumMoved: lowersEffect, as reportedRR0.88[0.78 to 0.99]Evidence: Moderatereplicated ×2Paper: PMID 215014352011
    Who
    Pregnant women in developing countries; pooled analysis of randomised controlled trials
    Dose studied
    not reported

    Calcium supplementation during pregnancy was also associated with a significant reduction in neonatal mortality [RR 0.70; 95 % CI 0.56-0.88] and risk of pre-term birth [RR 0.88, 95 % CI 0.78-0.99].”

    Quoted verbatim from Role of calcium supplementation during pregnancy in reducing risk of developing gestational hypertensive disorders: a meta-analysis of studies from developing countries.meta-analysisPermalink
  3. L-arginineMoved: lowersEvidence: ModeratePaper: PMID 348154602021Industry funded
    Who
    Pregnant women in pooled randomised trials with high risk of pre-eclampsia, or mild chronic hypertension; three studies, controls placebo or vitamins
    Dose studied
    oral L-arginine 3 to 6.6 g/day, pooled; one trial gave 6.6 g/day with vitamins against vitamins alone

    In comparison to controls, the oral l-arginine groups showed significantly reduced risks of IUGR neonates, pre-term birth and respiratory distress syndrome (n = 7, 3 and 3, respectively) in the total population.”

    Quoted verbatim from Effects of prenatal oral L-arginine on birth outcomes: a meta-analysis.meta-analysisPermalink
  4. ZincMoved: lowersEffect, as reportedRR0.86[0.76 to 0.97]Evidence: Very limitedreplicated ×1Paper: PMID 227864722012
    Who
    Pregnant women in 16 randomised trials of zinc supplementation in pregnancy · n = 7,637
    Dose studied
    not reported

    Zinc supplementation resulted in a small but significant reduction in preterm birth (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.76 to 0.97 in 16 RCTs; 16 trials of 7637 women).”

    Quoted verbatim from Zinc supplementation for improving pregnancy and infant outcome.meta-analysisPermalink
  5. CalciumMoved: lowersEffect, as reportedRR0.76[0.6 to 0.97]Evidence: Very limitedreplicated ×3Paper: PMID 206870642010
    Who
    Pregnant women in randomised trials of at least 1 g daily calcium versus placebo, overall estimate; most women low risk with a low calcium diet · n = 15,275
    Dose studied
    at least 1 g daily

    The average risk of preterm birth was reduced in the calcium group overall (11 trials, 15,275 women: RR 0.76, 95% CI 0.60 to 0.97) and amongst women at high risk of developing pre-eclampsia recruited to four small trials (568 women: RR 0.45, 95% CI 0.24 to 0.83).”

    Quoted verbatim from Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.meta-analysisPermalink
  6. CalciumMoved: lowersEffect, as reportedRR0.76[0.6 to 0.97]Evidence: Very limitedreplicated ×2Paper: PMID 302775792018
    Who
    Pregnant women; high-dose calcium supplementation (at least 1 g daily) versus placebo, pooled RCTs; whole-population estimate · n = 15,275
    Dose studied
    at least 1 g/day calcium during pregnancy

    The average risk of preterm birth was reduced in the calcium supplementation group (11 trials, 15,275 women: RR 0.76, 95% CI 0.60 to 0.97; I² = 60%; low-quality evidence); this reduction was greatest amongst women at higher risk of developing pre-eclampsia (four trials, 568 women: average RR 0.45, 95% CI 0.24 to 0.83; I² = 60%).”

    Quoted verbatim from Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.meta-analysisPermalink
  7. CalciumMoved: lowersEvidence: Very limitedreplicated ×2Paper: PMID 395600752024
    Who
    Pregnant women (multiple gestation excluded) in randomised trials of calcium supplementation versus placebo or no treatment, preterm birth before 37 weeks
    Dose studied
    not reported

    This review indicates that calcium supplementation probably reduces preterm birth before 37 weeks.”

    Quoted verbatim from Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.meta-analysisPermalink
  8. ZincMoved: lowersEffect, as reportedRR0.86[0.76 to 0.97]Evidence: Very limitedPaper: PMID 259271012015
    Who
    Pregnant women in randomised trials of zinc supplementation in pregnancy, pooled across 16 trials · n = 7,637
    Dose studied
    not reported

    Zinc supplementation resulted in a small reduction in preterm birth (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.76 to 0.97 in 16 RCTs; 16 trials of 7637 women).”

    Quoted verbatim from Zinc supplementation for improving pregnancy and infant outcome.meta-analysisPermalink
  9. Myo-inositolMoved: lowersEffect, as reportedRR0.35[0.17 to 0.7]Evidence: Very limitedPaper: PMID 367901382023
    Who
    Pregnant women 10 to 24 weeks pregnant at the start of the trials, pooled across four randomised trials (829 infants) · n = 829
    Dose studied
    not reported

    However, myo-inositol may be associated with a reduction in the incidence of preterm birth (RR 0.35, 95% CI 0.17 to 0.70; 4 studies; 829 infants).”

    Quoted verbatim from Antenatal dietary supplementation with myo-inositol for preventing gestational diabetes.meta-analysisPermalink

Measured, no difference found12 findings

  1. Vitamin A (retinol)Moved: no difference foundEvidence: Moderatereplicated ×3Paper: PMID 227426012012
    Who
    Pregnant women in pooled randomised trials of vitamin A supplementation during pregnancy, overall estimate including trials in HIV-positive women
    Dose studied
    3333 to 10,000 IU vitamin A daily-equivalent, varying across trials

    No significant overall effect was found of VA on preterm birth (<37 weeks) or early preterm birth (<34 weeks).”

    Quoted verbatim from Vitamin A and carotenoids during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis.meta-analysisPermalink
  2. Folic acidMoved: no difference foundEvidence: Moderatereplicated ×1Paper: PMID 355775772022An author is affiliated with a producer
    Who
    Norwegian MoBa cohort pregnancies of women with epilepsy not using antiseizure medication, and of women without epilepsy; periconceptional folic acid use versus none
    Dose studied
    not reported

    We found no association between folic acid supplement and preterm birth in the Epilepsy without ASM group or in the No epilepsy group (Table 2).”

    Quoted verbatim from Folic Acid and Risk of Preterm Birth, Preeclampsia, and Fetal Growth Restriction Among Women With Epilepsy: A Prospective Cohort Study.cohortPermalink
  3. Vitamin A (retinol)Moved: no difference foundEffect, as reportedRR0.88[0.65 to 1.19]Evidence: Very limitedreplicated ×3Paper: PMID 212496562011
    Who
    HIV-infected pregnant women; meta-analysis of randomised trials of antenatal vitamin A supplementation against placebo · n = 2,110
    Dose studied
    not reported

    However, antenatal vitamin A supplementation significantly improved birth weight (3 trials, 1809 women: MD 89.78, 95%CI 84.73 to 94.83; I(2)=33.0%), but there was no evidence of an effect on preterm births (3 trials, 2110 women: RR 0.88, 95%CI 0.65 to 1.19; I(2)=58.1%), stillbirths (4 trials, 2855 women: RR 0.99, 95%CI 0.68 to 1.43; I(2)=0%), deaths by 24 months (2 trials, 1635 women: RR 1.03, 95%CI 0.88 to 1.20; I(2)=0%), postpartum CD4 levels (1 trial, 727 women: MD -4.00, 95% CI -51.06 to 43.06), and maternal death ( 1 trial, 728 women: RR 0.49, 95%CI 0.04 to 5.37).”

    Quoted verbatim from Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection.meta-analysisPermalink
  4. Folic acidMoved: no difference foundEffect, as reportedRR1.01[0.73 to 1.38]Evidence: Very limitedreplicated ×1Paper: PMID 235435472013
    Who
    Pregnant women in randomised trials of oral folic acid alone or with other micronutrients versus no folic acid · n = 2,959
    Dose studied
    not reported

    This review found that folic acid supplementation has no impact on pregnancy outcomes such as preterm birth (risk ratio (RR) 1.01, 95% confidence interval (CI) 0.73 to 1.38; three studies, 2959 participants), and stillbirths/neonatal deaths (RR 1.33, 95% CI 0.96 to 1.85; three studies, 3110 participants).”

    Quoted verbatim from Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes.meta-analysisPermalink
  5. CalciumMoved: no difference foundEffect, as reportedRR0.81[0.64 to 1.03]Evidence: Very limitedreplicated ×1Paper: PMID 168559572006
    Who
    Pregnant women in 10 randomised trials of at least one gram daily of calcium versus placebo · n = 14,751
    Dose studied
    at least one gram daily during pregnancy

    There was no overall effect on the risk of preterm birth (10 trials, 14,751 women: RR 0.81, 95% CI 0.64 to 1.03), or stillbirth or death before discharge from hospital (10 trials 15,141 babies; RR 0.89, 95% CI 0.73 to 1.09).”

    Quoted verbatim from Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.meta-analysisPermalink
  6. CalciumMoved: no difference foundEffect, as reportedRR0.9[0.73 to 1.11]Evidence: Very limitedreplicated ×2Paper: PMID 219757612011
    Who
    Pregnant women in randomised trials of calcium supplementation versus placebo or no treatment, other than for preventing or treating hypertension · n = 15,615
    Dose studied
    not reported

    There were no statistically significant differences between women who received calcium supplementation and those who did not in terms of reducing preterm births (less than 37 weeks' gestation) (risk ratio (RR) 0.90; 95% confidence interval (CI) 0.73 to 1.11; 12 studies, 15615 women; random-effects model) and also in less than 34 weeks' gestation (RR 1.11; 95% CI 0.84 to 1.46; three trials, 5145 women).”

    Quoted verbatim from Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.meta-analysisPermalink
  7. CalciumMoved: no difference foundEffect, as reportedRR0.86[0.7 to 1.05]Evidence: Very limitedreplicated ×1Paper: PMID 259228622015
    Who
    Pregnant women; pooled randomised trials of calcium supplementation versus placebo or no treatment, for purposes other than preventing or treating hypertension · n = 16,139
    Dose studied
    not reported

    There were no statistically significant differences between women who received calcium supplementation and those who did not in terms of reducing preterm births less than 37 weeks' gestation (risk ratio (RR) 0.86, 95% confidence interval (CI) 0.70 to 1.05; 13 studies, 16,139 women; random-effects model) or less than 34 weeks' gestation (RR 1.04, 95% CI 0.80 to 1.36; four trials, 5669).”

    Quoted verbatim from Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes.meta-analysisPermalink
  8. MagnesiumMoved: no difference foundEvidence: Very limitedPaper: PMID 237286342013
    Who
    women with threatened preterm labour previously arrested by initial tocolysis, given magnesium maintenance therapy versus placebo/no treatment or versus alternative tocolytics (ritodrine or terbutaline) (Cochrane review of 4 RCTs, 422 women)
    Dose studied
    not reported

    No differences in the incidence of preterm birth or perinatal mortality were seen when magnesium maintenance therapy was compared with placebo or no treatment; or alternative therapies (ritodrine or terbutaline).”

    Quoted verbatim from Magnesium maintenance therapy for preventing preterm birth after threatened preterm labour.meta-analysisPermalink
  9. ZincMoved: no difference foundEffect, as reportedRR0.87[0.74 to 1.03]Evidence: Very limitedPaper: PMID 337244462021
    Who
    Pregnant women randomised before 27 weeks' gestation to zinc supplementation versus placebo or no zinc; 21 studies · n = 9,851
    Dose studied
    not reported

    The evidence suggests that zinc supplementation may result in little or no difference in reducing preterm births (risk ratio (RR) 0.87, 95% confidence interval (CI) 0.74 to 1.03; 21 studies, 9851 participants; low-certainty evidence).”

    Quoted verbatim from Zinc supplementation for improving pregnancy and infant outcome.meta-analysisPermalink
  10. IodineMoved: no difference foundEffect, as reportedRR0.71[0.3 to 1.66]Evidence: Very limitedPaper: PMID 282602632017
    Who
    Women supplemented with iodine in the preconception, pregnancy or postpartum period, in trials in mild to moderate iodine deficiency settings; trials pooled injected and oral iodine · n = 376
    Dose studied
    not reported

    There were no clear differences between groups for hypothyroidism in pregnancy or postpartum (pregnancy: average RR 1.90; 95% CI 0.57 to 6.38, one trial, 365 women, low-quality evidence, and postpartum: average RR 0.44; 95% CI 0.06 to 3.42, three trials, 540 women, no statistical heterogeneity, low-quality evidence), preterm birth (average RR 0.71; 95% CI 0.30 to 1.66, two trials, 376 women, statistical heterogeneity, low-quality evidence) or the maternal adverse effects of elevated thyroid peroxidase antibodies (TPO-ab) in pregnancy or postpartum (average RR 0.95; 95% CI 0.44 to 2.07, one trial, 359 women, low-quality evidence, average RR 1.01; 95% CI 0.78 to 1.30, three trials, 397 women, no statistical heterogeneity, low-quality evidence), or hyperthyroidism in pregnancy (average RR 1.90; 95% CI 0.57 to 6.38, one trial, 365 women, low-quality evidence).”

    Quoted verbatim from Iodine supplementation for women during the preconception, pregnancy and postpartum period.meta-analysisPermalink
  11. Vitamin A (retinol)Moved: no difference foundEvidence: Very limitedreplicated ×3Paper: PMID 231515322013
    Who
    Pregnant women in rural northwestern Bangladesh, cluster-randomised, placebo-controlled; vitamin A and a separate β-carotene arm each against placebo
    Dose studied
    not reported

    Neither gestational age nor preterm birth rate differed with vitamin A or β-carotene supplementation.”

    Quoted verbatim from Effects of vitamin A and β-carotene supplementation on birth size and length of gestation in rural Bangladesh: a cluster-randomized trial.RCTPermalink
  12. Vitamin A (retinol)Moved: no difference foundEvidence: Very limitedreplicated ×3Paper: PMID 210697072010
    Who
    Pregnant women; pooled randomised and quasi-randomised trials of antenatal vitamin A supplementation
    Dose studied
    not reported

    Overall when trial results are pooled, Vitamin A supplementation does not affect the risk of maternal mortality (risk ratio (RR) 0.78, 95% confidence interval (CI) 0.55 to 1.10, 3 studies, Nepal, Ghana,UK ), perinatal mortality, neonatal mortality, stillbirth, neonatal anaemia, preterm birth or the risk of having a low birthweight baby.”

    Quoted verbatim from Vitamin A supplementation during pregnancy for maternal and newborn outcomes.meta-analysisPermalink

How it is measured

Incidence of preterm birth, delivery before 37 completed weeks of gestation, ascertained from the delivery record. The population is recorded with each finding, because symptomatic women after arrested threatened preterm labour and an unselected pregnant population do not share a baseline rate.

Measured, with no finding

1 measurement

Show what was measuredHide what was measured
  • Preterm birth incidence

    the late-FAS group’s participants displayed the lowest incidences of preterm birth (9.4%)

    PMID 41515197 · one of two readings recorded this

Papers about it

As an endpoint43

Show the newest 12Hide the papers
  • Gestational exposure to metals and small vulnerable newborns: a systematic review and meta-analysis.

    Environment international2026PMID 41558207Via: named in the paper, as read

  • Birth outcomes following intrauterine exposure to electronic nicotine delivery systems: a systematic review and meta-analysis.

    Nicotine & tobacco research2026PMID 42176222Via: named in the paper, as read

  • Prenatal fluoride exposure and pregnancy outcomes in two US pregnancy cohorts.

    International journal of epidemiology2026PMID 42632752Via: named in the paper, as read

  • The association of dietary methionine, natural folate and folic acid supplementation with the risk of preterm birth during pregnancy: a case control study.

    BMC public health2026PMID 42983685Via: named in the paper, as read

  • Maternal periconception serum vitamin B12 concentration and risk of preterm birth: a prospective cohort study.

    BMJ open2025PMID 40436448Via: named in the paper, as read

  • Calcium supplementation commenced before pregnancy for preventing hypertensive disorders and related problems.

    The Cochrane database of systematic reviews2025PMID 40965861Via: named in the paper, as read

  • Duration of Folic Acid Supplementation and Adverse Pregnancy Outcomes: A Prospective Multicenter Cohort Study in China.

    Nutrients2025PMID 41515197Via: named in the paper, as read

  • Association of maternal prenatal copper concentration with gestational duration and preterm birth: a multicountry meta-analysis.

    The American journal of clinical nutrition2024PMID 37890672Via: named in the paper, as read

  • The efficacy of magnesium supplementation for gestational diabetes: A meta-analysis of randomized controlled trials.

    European journal of obstetrics, gynecology, and reproductive biology2024PMID 38128389Via: named in the paper, as read

  • Selenium levels and their association with thyroid autoimmunity and severe preeclampsia in pregnancy: Insights from a prospective ideal breast milk cohort study.

    European thyroid journal2024PMID 38888992Via: named in the paper, as read

  • Daily oral iron supplementation during pregnancy.

    The Cochrane database of systematic reviews2024PMID 39145520Via: named in the paper, as read

  • Is Oral Iron and Folate Supplementation during Pregnancy Protective against Low Birth Weight and Preterm Birth in Africa? A Systematic Review and Meta-Analysis.

    Nutrients2024PMID 39203937Via: named in the paper, as read

and 31 more.

Newest

  • Gestational exposure to metals and small vulnerable newborns: a systematic review and meta-analysis.

    Environment international2026PMID 41558207As an endpoint

  • Birth outcomes following intrauterine exposure to electronic nicotine delivery systems: a systematic review and meta-analysis.

    Nicotine & tobacco research2026PMID 42176222As an endpoint

  • Prenatal fluoride exposure and pregnancy outcomes in two US pregnancy cohorts.

    International journal of epidemiology2026PMID 42632752As an endpoint

  • The association of dietary methionine, natural folate and folic acid supplementation with the risk of preterm birth during pregnancy: a case control study.

    BMC public health2026PMID 42983685As an endpoint

  • Maternal periconception serum vitamin B12 concentration and risk of preterm birth: a prospective cohort study.

    BMJ open2025PMID 40436448As an endpoint

Sources cited

21 papers

Show the remaining 9Show the first 12